两剂 BNT162b2 SARS-CoV-2 疫苗后使用解热药与患有基础疾病的青少年和年轻成年人抗体滴度之间的关系。
Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases.
机构信息
Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department for Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
出版信息
J Infect Chemother. 2024 Feb;30(2):176-178. doi: 10.1016/j.jiac.2023.09.025. Epub 2023 Sep 27.
There are few reports on the association between antipyretic use and antibody titers in adolescents and young adults following SARS-CoV-2 vaccination. Multivariable linear regression analyses were performed to examine the association between antipyretic use and antibody titers. The use of antipyretics was not associated with antibody titers (β coefficient [95% CI] = -0.107 [-0.438 to 0.224]).
关于退热剂使用与青少年和年轻成年人接种 SARS-CoV-2 疫苗后的抗体滴度之间的关系，目前鲜有报道。本研究采用多变量线性回归分析来检验退热剂使用与抗体滴度之间的关系。退热剂的使用与抗体滴度无关（β系数[95%CI] = -0.107[-0.438 至 0.224]）。
Zotero 插件